课题基金 / 基金详情

Examining potential inequities in access to take-home opioid agonist treatment doses ('carries') and related outcomes

Examining potential inequities in access to take-home opioid agonist treatment doses ('carries') and related outcomes
检查带回家的阿片类激动剂治疗剂量(“携带”)和相关结果方面的潜在不平等
批准号:
460522
负责人:
Lange Shannon
金额:
$0.73万
依托单位国家:
加拿大
项目类别:
Miscellaneous Programs
财政年份:
2022
资助国家:
加拿大
项目状态:
已结题
起止时间:
2022-02-01 至 2023-02-01

项目摘要

项目成果

Lange Shannon的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Opioid use and related harms have been steadily increasing in Canada, particularly in the province of Ontario. Thus, opioid use disorder (OUD) is a major public health concern. Opioid agonist treatment (OAT) is the primary pharmacological treatment for OU
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Alcohol use disorders and the risk of suicidal behaviour: A sex/gender-specific investigation
海外基金